Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.
about
Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk.Elevated N-terminal pro-brain natriuretic peptide is associated with mortality in tobacco smokers independent of airflow obstruction.Association of glomerular filtration rate with high-sensitivity cardiac troponin T in a community-based population study in BeijingB-type natriuretic peptide-guided therapy for perioperative medicine?Risk factors for cardiovascular disease across the spectrum of older age: the Cardiovascular Health Study.Predictive value of depressive symptoms and B-type natriuretic peptide for new-onset heart failure and mortality.Association between resting heart rate and N-terminal pro-brain natriuretic peptide in a community-based population study in Beijing.Effect of enhanced external counterpulsation treatment on renal function in cardiac patients.Serial measurements of N-terminal pro-brain natriuretic peptide in patients with coronary heart disease.NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.Direct comparison of serial B-type natriuretic peptide and NT-proBNP levels for prediction of short- and long-term outcome in acute decompensated heart failure.Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study).Cardiac microinjury measured by troponin T predicts collagen metabolism in adults aged >=65 years with heart failure.Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study.Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).Impact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes.Total and high-molecular-weight adiponectin and risk of coronary heart disease and ischemic stroke in older adultsLeft ventricular ejection fraction assessment in older adults: an adjunct to natriuretic peptide testing to identify risk of new-onset heart failure and cardiovascular death?Relation of vitamin D and parathyroid hormone to cardiac biomarkers and to left ventricular mass (from the Cardiovascular Health Study)Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.Heart failure in older adults: embracing complexity.N-Terminal Pro-Brain Natriuretic Peptide and Heart Failure Risk Among Individuals With and Without Obesity: The Atherosclerosis Risk in Communities (ARIC) Study.Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapyPhysical activity, change in biomarkers of myocardial stress and injury, and subsequent heart failure risk in older adultsSoluble ST2 for Prediction of Heart Failure and Cardiovascular Death in an Elderly, Community-Dwelling PopulationN-terminal pro-B-type natriuretic peptide is associated with sudden cardiac death risk: the Cardiovascular Health Study.N-terminal pro-brain natriuretic peptide and cardiovascular or all-cause mortality in the general population: A meta-analysisAssociations of total and high-molecular-weight adiponectin with all-cause and cardiovascular mortality in older persons: the Cardiovascular Health Study.Variability of biomarkers in patients with chronic heart failure and healthy controls.B-type natriuretic peptides: looking to the future.Heart failure treatment in the elderly.Prevention of heart failure in the elderly: when, where and how to begin?Subclinical Atherosclerosis, Cardiac and Kidney Function, Heart Failure, and Dementia in the Very Elderly.Natriuretic peptides: Diagnostic and therapeutic use.Bone Mineral Density and Risk of Heart Failure in Older Adults: The Cardiovascular Health Study.Longitudinal assessment of N-terminal pro-B-type natriuretic peptide and risk of diabetes in older adults: The cardiovascular health study.Increase in N-terminal pro-brain natriuretic peptide levels, renal function and cardiac disease in the oldest old.Ultra-Sensitive NT-proBNP Quantification for Early Detection of Risk Factors Leading to Heart Failure.Natriuretic peptide and cardiovascular risk: is it about "U"?
P2860
Q33551467-5806DB63-C697-42B3-9771-0DC0070BDD57Q33873812-C4D8C976-F803-4353-B6E0-7F33402F9AEDQ34075676-8F9F20E4-5BF9-4057-B665-367D91F67BF8Q34295470-1AAC79EB-89F6-410D-8774-40EF81E7CC9CQ34304406-31128D14-4CEA-4416-B844-E70F6422C80CQ34623834-875CD1FF-262D-42A2-8483-003AA9B64EECQ34700507-0B59B94F-1996-4AC8-B706-6DC2D92A6F42Q34787204-F2CDB22A-503A-4A8C-959F-F4FBC03ED96AQ34983153-7DD81813-B657-4CA3-9968-DE891FA2D82AQ35022912-E6156CB0-7375-4F1E-97C6-43C9A35D32A5Q35051193-3888E470-9A52-4161-AD46-7147C9625E29Q35567128-D20A630C-34C1-44F3-B181-A158BE2E2C83Q35690501-92C7F007-C5DE-4518-8C34-C4C68C33B245Q35777180-5B90F495-C0C7-4D05-B98E-1F0398254EB6Q35802753-FF4D714D-3D61-4346-B4E7-72E2591C1B62Q36385601-E11CF8CD-7FDC-4AAB-800E-DD9958CF06B2Q36433506-61F6306B-798D-4EAB-B216-202A21E46E60Q36508893-0EAEEAC5-1A40-4D7E-8600-60143AB1356CQ36520069-9203DE84-182B-4861-818C-534835B745E4Q36536486-E1B94B2F-2605-4F73-B547-D3F27CE65E37Q36574151-9EEA9276-56C5-49B4-810E-9F47EF5ED861Q36578414-DAD8F767-9D2B-4660-8650-66FB30BA8A81Q36593924-36620AF2-6B89-4714-A486-5D066A70F142Q36642014-21D40468-7694-4B8A-A44B-46253E3C1D9AQ36665888-27F48DCA-B745-4261-A0E8-618040892930Q37240346-C9B4217E-4815-46A8-A06F-E57ADD890421Q37304997-8173DD6A-DAEB-4F7C-8094-1EACCD3723E0Q37612412-3044513A-C758-455E-B20E-4EEE4B47603DQ37669745-4C7E6187-9715-427C-8A89-05858C161770Q37696493-AC055E53-1779-4A66-903D-122FE0D78EE4Q37801667-BC5FD6CD-9974-4A30-816E-0B6B453C9A56Q37935778-1B087537-4265-49DD-BC78-DDB596027D0AQ37978190-8AF9653F-F492-4938-ACCE-164B7DC8E036Q38373457-30D7C41F-6760-4B80-ADA8-B8CE0A5E0170Q39581832-35218257-9635-46DB-B58E-46A7F0F5A2CEQ40294390-6C1B463E-BC96-4985-B9D9-CC549300E97EQ40584596-5077C5C8-E6E6-460E-8D70-31902496DBF4Q41548532-5E5BAB24-BD48-42A6-A067-4897EF43AEC5Q41875333-8CE7B440-2CD8-4EBA-A922-4973A5C0666FQ43228079-5206AB2E-9AD0-419B-8045-C540D0DB5FE2
P2860
Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Dynamic cardiovascular risk as ...... e natriuretic peptide testing.
@ast
Dynamic cardiovascular risk as ...... e natriuretic peptide testing.
@en
type
label
Dynamic cardiovascular risk as ...... e natriuretic peptide testing.
@ast
Dynamic cardiovascular risk as ...... e natriuretic peptide testing.
@en
prefLabel
Dynamic cardiovascular risk as ...... e natriuretic peptide testing.
@ast
Dynamic cardiovascular risk as ...... e natriuretic peptide testing.
@en
P2093
P2860
P1476
Dynamic cardiovascular risk as ...... pe natriuretic peptide testing
@en
P2093
Christopher R deFilippi
John S Gottdiener
Robert H Christenson
Willem J Kop
P2860
P304
P356
10.1016/J.JACC.2009.07.069
P407
P577
2010-02-01T00:00:00Z